[VRDN] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
27-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- -89.51%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 314 1,772 2,963 1,050 4,461 8,386 4,003 -34.56%
PBT -237,734 -129,874 -79,413 -110,715 -41,873 -32,703 -26,512 44.11%
Tax 18,563 -4,430 3 269 547 1,254 95 140.79%
NP -237,734 -125,444 -79,416 -110,984 -42,420 -32,703 -26,512 44.11%
Tax Rate - - - - - - - -
Total Cost 238,048 127,216 82,379 112,034 46,881 41,089 30,515 40.80%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -75,711.46 -7,079.23 -2,680.26 -10,569.90 -950.91 -389.97 -662.30 120.22%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -5.31 -3.91 -6.66 -31.20 -20.31 -16.57 -20.66 -20.25%
EPS Diluted -5.31 -3.91 -6.66 -31.20 -20.31 -16.57 -20.66 -20.25%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.